Filtros : "Sá, Vanessa de" Limpar

Filtros



Refine with date range


  • Source: Drug Combination Therapy. Unidade: IQ

    Subjects: MEDICAMENTO, TERAPIA COMBINADA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MELLO, Renata Siqueira de et al. Complex diseases demand novel treatment strategies: understanding drug combination. Drug Combination Therapy, v. 4, n. 2, p. 1-12 art. 6, 2022Tradução . . Disponível em: https://doi.org/10.53388/DCT2022006. Acesso em: 27 abr. 2024.
    • APA

      Mello, R. S. de, Sampaio, V. F. A., Maciel, L. F., Sá, V. de, Glaser, T., Ulrich, H., & Lameu, C. (2022). Complex diseases demand novel treatment strategies: understanding drug combination. Drug Combination Therapy, 4( 2), 1-12 art. 6. doi:10.53388/DCT2022006
    • NLM

      Mello RS de, Sampaio VFA, Maciel LF, Sá V de, Glaser T, Ulrich H, Lameu C. Complex diseases demand novel treatment strategies: understanding drug combination [Internet]. Drug Combination Therapy. 2022 ; 4( 2): 1-12 art. 6.[citado 2024 abr. 27 ] Available from: https://doi.org/10.53388/DCT2022006
    • Vancouver

      Mello RS de, Sampaio VFA, Maciel LF, Sá V de, Glaser T, Ulrich H, Lameu C. Complex diseases demand novel treatment strategies: understanding drug combination [Internet]. Drug Combination Therapy. 2022 ; 4( 2): 1-12 art. 6.[citado 2024 abr. 27 ] Available from: https://doi.org/10.53388/DCT2022006
  • Source: Journal of thoracic oncology. Conference titles: World conference on lun cancer - ASLC. Unidade: FM

    Subjects: METÁSTASE NEOPLÁSICA, ADENOCARCINOMA, CARCINOMA NEUROENDÓCRINO, NEOPLASIAS PULMONARES

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PRIETO, Tabatha et al. Gene signature of EMT in neuroendocrine lung carcinoma: a comparative analysis with adenocarcinoma and squamous cell carcinoma. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 27 abr. 2024. , 2017
    • APA

      Prieto, T., Sá, V. de, Olivieri, E. H. R., Silva, E. da, Reis, R., Carraro, D., & Capelozzi, V. L. (2017). Gene signature of EMT in neuroendocrine lung carcinoma: a comparative analysis with adenocarcinoma and squamous cell carcinoma. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
    • NLM

      Prieto T, Sá V de, Olivieri EHR, Silva E da, Reis R, Carraro D, Capelozzi VL. Gene signature of EMT in neuroendocrine lung carcinoma: a comparative analysis with adenocarcinoma and squamous cell carcinoma [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S714-S715.[citado 2024 abr. 27 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
    • Vancouver

      Prieto T, Sá V de, Olivieri EHR, Silva E da, Reis R, Carraro D, Capelozzi VL. Gene signature of EMT in neuroendocrine lung carcinoma: a comparative analysis with adenocarcinoma and squamous cell carcinoma [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S714-S715.[citado 2024 abr. 27 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024